Status:
COMPLETED
In Vivo Study of Local Tranexamic Acid Concentrations Following Intra-Articular Administration in Total Knee Arthroplasty
Lead Sponsor:
Valdoltra Orthopedic Hospital
Collaborating Sponsors:
University of Ljubljana, Faculty of Medicine
Conditions:
Local Concentration of Tranexamic Acid Following Intra-articular Administration in TKA
Eligibility:
All Genders
40-85 years
Brief Summary
The goal of this observational study is to measure local tranexamic acid (TXA) concentrations following intra-articular administration in patients undergoing total knee arthroplasty. By evaluating its...
Eligibility Criteria
Inclusion
- diagnosis of advanced osteoarthritis of the knee joint
Exclusion
- known allergy to TXA
- family history or past spontaneous thromboembolic event
- pathological preoperative blood analysis
- advanced heart failure (NYHA \> 2)
- ischemic heart disease
- epilepsy
Key Trial Info
Start Date :
August 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06876181
Start Date
August 23 2022
End Date
September 30 2024
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Valdoltra Orthopaedic Hospital
Ankaran, Ajdovščina Municipality, Slovenia, 6280